Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies – MDPI – 2019

Publication
Jan. 12, 2022

This special Issue related to newborn screening for Sickle Cell disease and other hemoglobinopathies tried to cover the most widely faced challenges in the field of newborn screening for SCD.

Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab

Publication
Aug. 09, 2021

Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.

Further evaluation of the world health organization international reference reagent for Haemoglobin A2 measurement

Publication
May. 10, 2021

This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.

Precision of CAPILLARYS 2 for the Detection of Hemoglobin Variants Based on Their Migration Positions

Publication
May. 10, 2021

In this report, we evaluated the use of the capillary electrophoresis (CE) migration position in the CAPILLARYS 2 CE instrument.

EurA1c trial

Publication
May. 06, 2021

The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers.

The impact of red blood cell lifespan on HbA1c measurement

Publication
May. 06, 2021

This article reminds the reader of the importance of detecting the Hb variants when measuring HbA1c for the labs and clinicians to better interpret the results and to ensure optimal management of the diabetic patient.

Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods

Publication
May. 06, 2021

Hemoglobin C, D Punjab, E or S trait can interfere with hemoglobin A1c (HbA1c) results depending on the method of analysis used. Therefore, it is important to know the limitations of the method used for HbA1c determination.

von Willebrand Factor and COVID-19

Publication
Apr. 30, 2021

Correlation of von Willebrand factor with the severity of COVID-9 progression.

Improving diagnosis of von Willebrand disease

Publication
Apr. 30, 2021

Multimer analysis to improve von Willebrand disease classification with Hydragel vWF multimer Sebia.

Evaluation of a semi-automated von Willebrand factor multimer assay

Publication
Apr. 30, 2021

Algorithm for congenital and acquired von Willebrand disease includes Hydragel vWF multimer analysis.

2005 Multiple Sclerosis Consensus Criteria

Publication
Apr. 30, 2021

2005 Multiple sclerosis consensus criteria includes CSF IgG oligoclonal bands.

2017 Mc Donald Criteria for multiple sclerosis diagnosis

Publication
Apr. 30, 2021

2017 Mc Donald Criteria for multiple sclerosis diagnosis includes CSF IgG oligoclonal bands.